Medical Devices Investors & VC Firms
1393 firms in this list, with a median first check of $500K. 266 of them lead rounds. Generated from verified public data and updated continuously.
LSP (Life Sciences Partners)
AmsterdamSeries A–Late Stage$10.8M – $64.8M
8 people
Targeted Technology Funds
San AntonioSeed–Series A
5 people
Verge Fund
AlbuquerquePre-Seed–Series A$100K – $500K
8 people
Kama Flow
MoscowSeed–Late Stage
2 people
Cycad Group LLC
Santa BarbaraSeed–Late Stage
4 people
NGT Healthcare 2
NazarethPre-Seed–Series A
7 people
Averin Capital
New YorkSeed–Growth
9 people
Bullnet Gestión SGECR, S. A.
Pozuelo de AlarcónPre-Seed–Series A$1.1M – $4.3M
Cure Kids Ventures
AucklandSeed–Growth
6 people
Pivotal bioVenture Partners
San FranciscoSeed–Late Stage
12 people
Almeda Ventures
Tel AvivSeed–Late Stage
11 people
Fresenius Medical Care Ventures
Bad HomburgSeed–Late Stage
8 people
PureTech Health
Boston
11 people
Tramway Venture Partners
New MexicoSeed–Series A$30M
8 people
SATUS Venture Sp. z o.o.
KrakówPre-Seed–Series A$108K – $6.5M
2 people
Liebenthal Ventures
Old WestburyPre-Seed–Series A$25K – $500K
1 person
20/20 HealthCare Partners LLC
AuburndaleSeed–Late Stage
7 people
Angelini Ventures
RomeSeed–Growth
4 people
Avego BioScience Capital
AlpharettaSeries A–Late Stage
InnoCom Bio Equities
San FranciscoPre-Seed–Series A
9 people
Ming capital
ShenzhenSeed–Late Stage
6 people
Ontario Centre of Innovation programs
TorontoPre-Seed–Growth
3 people
Red Bear Angels
IthacaSeed–Series A$100K – $1M
3 people
Toledo Capital AG
ZurichSeed–Late Stage
12 people
Related lists
Investors & VC Firms in United States (5050)Crypto & Web3 Investors & VC Firms (4688)Investors & VC Firms in Global (4044)SaaS Investors & VC Firms (3602)AI & Machine Learning Investors & VC Firms (3577)Fintech Investors & VC Firms (3506)Healthtech Investors & VC Firms (3208)Enterprise Software Investors & VC Firms (3098)Investors & VC Firms in Europe (2833)Consumer Investors & VC Firms (2381)
Data sourced from public filings and firms' own websites — see our methodology.























































